Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 87 for:    salt intake and hypertension

A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02920437
Recruitment Status : Terminated (The study cannot recruit the expected number of participants. Only 19 participants were recruited and no more new participant was recruited after that.)
First Posted : September 30, 2016
Last Update Posted : April 18, 2019
Sponsor:
Information provided by (Responsible Party):
Dr. Pui-Hing Chau, The University of Hong Kong

Brief Summary:
A pilot randomized controlled trial will be conducted to investigate the feasibility and effectiveness of a salt intake reduction intervention to young hypertension patients in Hong Kong who had high salt intake.

Condition or disease Intervention/treatment Phase
Hypertension Behavioral: Four-week weekly intervention to reduce salt intake Other: Usual government pamphlets Not Applicable

Detailed Description:
Convenience sample will be recruited from the community in Hong Kong through different channels of promotion.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 19 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong
Actual Study Start Date : October 2016
Actual Primary Completion Date : October 2017
Actual Study Completion Date : October 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sodium

Arm Intervention/treatment
Experimental: Intervention group
Four-week weekly intervention to reduce salt intake.
Behavioral: Four-week weekly intervention to reduce salt intake
The intervention group will receive a four-week weekly intervention, about 15 minutes each. Two sessions will be face-to-face and two sessions will be on the phone. The participants will be informed of their 24-hour urinary sodium excretion at each measurement time once available.

Control group
Usual government pamphlets.
Other: Usual government pamphlets
The control group will receive usual government pamphlets when they know their 24-hour urinary sodium excretion at baseline. However, they will not be informed of their follow-up urinary sodium excretion results immediately.




Primary Outcome Measures :
  1. 24-hour urinary sodium excretion [ Time Frame: 10-Week ]
    Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up


Secondary Outcome Measures :
  1. Health literacy on low salt intake [ Time Frame: 10-Week ]
    Difference between the intervention and control group in the change in health literacy on low salt intake measured with the validated Chinese Health Literacy Scale for Low Salt Consumption (CHLSalt-HK)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 44 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • i) adults aged 18 to 44
  • ii) diagnosed hypertension or borderline hypertension
  • iii) complete collection of 24-hour urine at baseline
  • iv) 24-hour urinary sodium excretion above 2000mg at baseline
  • v) can communicate in Cantonese

Exclusion Criteria:

  • i) renal illnesses;
  • ii) taking diuretics;
  • iii) taking RAS blockers;
  • iv) attending or planning to attend new hypertension education programme or salt intake reduction programme during the study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02920437


Locations
Layout table for location information
China
School of Nursing, The University of Hong Kong
Hong Kong, China
Sponsors and Collaborators
The University of Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: Chau Pui Hing, PhD School of Nursing, The University of Hong Kong

Layout table for additonal information
Responsible Party: Dr. Pui-Hing Chau, Assistant Professor, The University of Hong Kong
ClinicalTrials.gov Identifier: NCT02920437     History of Changes
Other Study ID Numbers: UW 16-280
First Posted: September 30, 2016    Key Record Dates
Last Update Posted: April 18, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Dr. Pui-Hing Chau, The University of Hong Kong:
dietary salt
24 hour urinary sodium excretion
blood pressure
hypertension
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases